Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome

The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common c...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 120; no. 23; pp. 4599 - 4608
Main Authors Funderburg, Nicholas T., Zidar, David A., Shive, Carey, Lioi, Anthony, Mudd, Joseph, Musselwhite, Laura W., Simon, Daniel I., Costa, Marco A., Rodriguez, Benigno, Sieg, Scott F., Lederman, Michael M.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 29.11.2012
Americain Society of Hematology
American Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common cellular profiles. Nonclassic (CD14+CD16++) and intermediate (CD14++CD16+) monocytes are proportionally increased and express high levels of tissue factor and CD62P in HIV-1 infection. These proportions are related to viremia, T-cell activation, and plasma levels of IL-6. In vitro exposure of whole blood samples from uninfected control donors to lipopolysaccharide increased surface tissue factor expression on all monocyte subsets, but exposure to HIV-1 resulted in activation only of nonclassic monocytes. Remarkably, the profile of monocyte activation in uncontrolled HIV-1 disease mirrors that of acute coronary syndrome in uninfected persons. Therefore, drivers of immune activation and inflammation in HIV-1 disease may alter monocyte subpopulations and activation phenotype, contributing to a pro-atherothrombotic state that may drive cardiovascular risk in HIV-1 infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood-2012-05-433946